Showing results (2041-2050 of 3,796) with videos related to
Sort By:
Pageof 380
Oncoimmunology|September 17, 2020
The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisionsFranck Pagès, Julien Taieb, Pierre Laurent-Puig, et al.Oncoimmunology|November 20, 2019
Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitorsSi Yang, Ying Wu, Yujiao Deng, et al.Oncoimmunology|November 20, 2019
Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancerHeather L MacGregor, Carlos Garcia-Batres, Azin Sayad, et al.Oncoimmunology|November 20, 2019
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanomaNausicaa Malissen, Nicolas Macagno, Samuel Granjeaud, et al.Oncoimmunology|November 20, 2019
First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitorsSebastian Klein, Oana-Diana Persa, Cornelia Mauch, et al.Oncoimmunology|February 1, 2020
Targeting ST2 expressing activated regulatory T cells in Kras-mutant lung cancerByung-Seok Kim, Jelita Clinton, Qing Wang, et al.Oncoimmunology|February 1, 2020
Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasisJunko Johansson, Roberta Kiffin, Ebru Aydin, et al.Oncoimmunology|February 1, 2020
B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse modelsBaozhu Huang, Liqun Luo, Jun Wang, et al.Oncoimmunology|February 1, 2020
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncologyIsaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, et al.Pageof 380